Suppr超能文献

艰难梭菌感染患者经粪菌移植后复发性尿路感染的缓解:一例报告

rUTI Resolution After FMT for Clostridioides difficile Infection: A Case Report.

作者信息

Aira Andrea, Rubio Elisa, Vergara Gómez Andrea, Fehér Csaba, Casals-Pascual Climent, González Begoña, Morata Laura, Rico Verónica, Soriano Alex

机构信息

Department of Infectious Diseases, Hospital Clinic, Barcelona, Spain.

Department of Microbiology, Hospital Clinic, Barcelona, Spain.

出版信息

Infect Dis Ther. 2021 Jun;10(2):1065-1071. doi: 10.1007/s40121-020-00365-8. Epub 2020 Nov 2.

Abstract

Clostridioides difficile infection (CDI) is the leading cause of nosocomial infectious diarrhea. Fecal microbiota transplantation (FMT) is a successful treatment for recurrent CDI (rCDI), and in some patients FMT has been associated with the resolution of recurrent urinary tract infections (rUTI). Recent evidence suggests that the origin of most bacterial infections in the urinary tract is the gut. Thus, the possibility of using FMT to displace pathogens commonly involved in rUTIs has major therapeutic implications. We report the case of a 93-year-old female patient with a rCDI and rUTI that underwent FMT and reported a complete clinical resolution of CDI; unexpectedly, no new symptomatic UTI episodes were diagnosed post-FMT. We characterized the gut microbiota of the stool donor and of the patient before and after the procedure. Our patient presented a dysbiosis with clear predominance of Enterobacteriaceae (74%) before FMT, which was significantly reduced to 0.07% after FMT. These findings were maintained for almost a year. We also observed an increase in microbial diversity indices compared with the pre-FMT sample reaching diversity values comparable to the donor stool samples. We reasoned that the disappearance of UTIs in our patient resulted from the reduction of Enterobacteriaceae in the gut microbiota. Our findings support previous evidence suggesting the potential of FMT for rUTI, particularly in cases due to multi-drug resistant pathogens where conventional antibiotic treatment is not an option.

摘要

艰难梭菌感染(CDI)是医院获得性感染性腹泻的主要原因。粪便微生物群移植(FMT)是复发性CDI(rCDI)的一种成功治疗方法,在一些患者中,FMT与复发性尿路感染(rUTI)的缓解有关。最近的证据表明,大多数泌尿系统细菌感染的源头是肠道。因此,使用FMT替代rUTIs中常见病原体的可能性具有重大治疗意义。我们报告了一例93岁女性患者,患有rCDI和rUTI,接受了FMT治疗,报告显示CDI临床完全缓解;出乎意料的是,FMT后未诊断出新的有症状UTI发作。我们对粪便供体和患者在手术前后的肠道微生物群进行了特征分析。我们的患者在FMT前表现出菌群失调,肠杆菌科明显占优势(74%),FMT后显著降至0.07%。这些发现持续了近一年。我们还观察到与FMT前样本相比,微生物多样性指数有所增加,达到了与供体粪便样本相当的多样性值。我们推断患者UTI消失是由于肠道微生物群中肠杆菌科减少所致。我们的研究结果支持了先前的证据,表明FMT对rUTI具有潜在作用,特别是在由多重耐药病原体引起的病例中,传统抗生素治疗不是一种选择的情况下。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验